<VariationArchive VariationID="529473" VariationName="NM_001032386.2(SUOX):c.363dup (p.Pro122fs)" VariationType="Duplication" Accession="VCV000529473" Version="8" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2018-05-28" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="527277" VariationID="529473">
      <GeneList>
        <Gene Symbol="SUOX" FullName="sulfite oxidase" GeneID="6821" HGNC_ID="HGNC:11460" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="55997276" stop="56005525" display_start="55997276" display_stop="56005525" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="56391042" stop="56399308" display_start="56391042" display_stop="56399308" Strand="+" />
          </Location>
          <OMIM>606887</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001032386.2(SUOX):c.363dup (p.Pro122fs)</Name>
      <CanonicalSPDI>NC_000012.12:56003746:GGGGGG:GGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>12q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="56003746" stop="56003747" display_start="56003746" display_stop="56003747" variantLength="1" positionVCF="56003746" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="56397530" stop="56397531" display_start="56397530" display_stop="56397531" variantLength="1" positionVCF="56397530" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>P122fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.56397536dup" Assembly="GRCh37">
            <Expression>NC_000012.11:g.56397536dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.56003752dup" Assembly="GRCh38">
            <Expression>NC_000012.12:g.56003752dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008136.1" sequenceAccession="NG_008136" sequenceVersion="1" change="g.11494dup">
            <Expression>NG_008136.1:g.11494dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000456.3" sequenceAccession="NM_000456" sequenceVersion="3" change="c.363dup">
            <Expression>NM_000456.3:c.363dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000447.2" sequenceAccession="NP_000447" sequenceVersion="2" change="p.Pro122fs">
            <Expression>NP_000447.2:p.Pro122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001032386.2" sequenceAccession="NM_001032386" sequenceVersion="2" change="c.363dup" MANESelect="true">
            <Expression>NM_001032386.2:c.363dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001027558.1" sequenceAccession="NP_001027558" sequenceVersion="1" change="p.Pro122fs">
            <Expression>NP_001027558.1:p.Pro122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001032387.2" sequenceAccession="NM_001032387" sequenceVersion="2" change="c.363dup">
            <Expression>NM_001032387.2:c.363dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001027559.1" sequenceAccession="NP_001027559" sequenceVersion="1" change="p.Pro122fs">
            <Expression>NP_001027559.1:p.Pro122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000456.2" sequenceAccession="NM_000456" sequenceVersion="2" change="c.363dupG">
            <Expression>NM_000456.2:c.363dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA480179743" DB="ClinGen" />
        <XRef Type="rs" ID="1555198521" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001032386.2(SUOX):c.363dup (p.Pro122fs) AND Sulfite oxidase deficiency" Accession="RCV002254556" Version="13">
        <ClassifiedConditionList TraitSetID="6507">
          <ClassifiedCondition DB="MedGen" ID="C0268624">Sulfite oxidase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-08-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-08-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-05-28" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12112661</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23994568</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24938149</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28629418</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6507" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3860" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Sulfite oxidase deficiency</ElementValue>
                <XRef ID="Sulfite+oxidase+deficiency/6924" DB="Genetic Alliance" />
                <XRef ID="HP:0003643" DB="Human Phenotype Ontology" />
                <XRef ID="367368009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Isolated sulfite oxidase deficiency</ElementValue>
                <XRef ID="MONDO:0010089" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5062" />
                <XRef ID="5062" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of isolated sulfite oxidase deficiency ranges from classic early-onset (severe) disease to late-onset (mild) disease. Classic ISOD is characterized in the first few hours to days of life by intractable seizures, feeding difficulties, and rapidly progressive encephalopathy manifest as abnormal tone (especially opisthotonus, spastic quadriplegia, and pyramidal signs) followed by progressive microcephaly and profound intellectual disability. Lens subluxation or dislocation, another characteristic finding, may be evident after the newborn period. Children usually die during the first few months of life. Late-onset ISOD manifests between ages six and 18 months and is characterized by ectopia lentis (variably present), developmental delay/regression, movement disorder characterized by dystonia and choreoathetosis, ataxia, and (rarely) acute hemiplegia as a result of metabolic stroke. The clinical course may be progressive or episodic. In the episodic form encephalopathy, dystonia, choreoathetosis, and/or ataxia are intermittent.</Attribute>
                <XRef ID="NBK453433" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28933809</ID>
                <ID Source="BookShelf">NBK453433</ID>
              </Citation>
              <XRef ID="833" DB="Orphanet" />
              <XRef ID="99731" DB="Orphanet" />
              <XRef ID="C0268624" DB="MedGen" />
              <XRef ID="MONDO:0010089" DB="MONDO" />
              <XRef Type="MIM" ID="272300" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003643" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1465751" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="2604330|MedGen:C0268624" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000756295" DateUpdated="2024-02-14" DateCreated="2018-05-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-08-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12112661</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23994568</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24938149</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28629418</ID>
          </Citation>
          <Comment>This variant has not been reported in the literature in individuals with SUOX-related disease. For these reasons, this variant has been classified as Pathogenic. A different truncation downstream of this variant (p.Tyr400*) has been determined to be pathogenic (PMID: 12112661, 23994568, 24938149, 28629418). This suggests that deletion of this region of the SUOX protein is causative of disease. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the SUOX gene (p.Pro122Alafs*29). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 424 amino acids (80%) of the SUOX protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SUOX" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.56397530_56397531insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268624" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB3864685</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1465751" TraitType="Disease" MappingType="XRef" MappingValue="C0268624" MappingRef="MedGen">
        <MedGen CUI="C0268624" Name="Sulfite oxidase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

